Related Experiment Videos
Vitamin E and vascular homeostasis: implications for atherosclerosis
J F Keaney1, D I Simon, J E Freedman
1Evans Memorial Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, 02118, USA. jkeaney@bu.edu
Summary
Dietary vitamin E intake may lower cardiovascular disease risk. Vitamin E influences nitric oxide, smooth muscle cells, and platelets, potentially by inhibiting protein kinase C.
Area of Science:
- Nutritional Science
- Cardiovascular Research
- Biochemistry
Background:
- Epidemiologic studies link dietary vitamin E to reduced cardiovascular disease (CVD) incidence.
- The exact mechanisms by which vitamin E confers cardiovascular protection remain under investigation.
- Emerging evidence suggests multiple biological activities of vitamin E contribute to vascular health.
Purpose of the Study:
- To explore the potential mechanisms through which vitamin E may reduce cardiovascular disease.
- To highlight the role of vitamin E in vascular homeostasis and its impact on atherosclerosis.
Main Methods:
- Review of existing epidemiologic data on vitamin E and cardiovascular health.
- Analysis of emerging research on the molecular activities of vitamin E in vascular tissues.
- Focus on the inhibition of protein kinase C (PKC) as a unifying mechanism.
Main Results:
- Vitamin E demonstrates multiple vascular-protective activities, including enhancing nitric oxide bioactivity.
- Vitamin E inhibits vascular smooth muscle cell proliferation, a key factor in atherosclerosis.
- Vitamin E limits platelet aggregation, reducing the risk of thrombotic events.
- Inhibition of protein kinase C (PKC) stimulation by vitamin E is proposed as a common mechanistic pathway.
Conclusions:
- Vitamin E possesses diverse biological functions that likely contribute to its cardioprotective effects.
- Inhibition of PKC by vitamin E may be a critical mechanism for maintaining vascular homeostasis.
- These actions of vitamin E are expected to reduce the clinical incidence of cardiovascular disease, particularly in the context of atherosclerosis.